Slfn13 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of Schlafen family member 13 (Slfn13), a protein belonging to the Schlafen family of proteins. This family is known for its involvement in the regulation of cell proliferation, differentiation, and various cellular processes. Slfn13, in particular, has been found to exhibit distinct roles in the modulation of gene expression, cellular stress responses, and immune system regulation. Inhibitors of Slfn13 are designed to bind to key active sites or regulatory domains of the protein, preventing it from performing its biological functions. By inhibiting the activity of Slfn13, these compounds can alter cellular pathways that depend on the proper functioning of this protein, affecting downstream signaling networks that play a role in maintaining homeostasis within the cell.
The mechanisms of action for Slfn13 inhibitors are varied and may include blocking the protein's interaction with other cellular factors, interfering with its enzymatic activity, or disrupting its structural conformation. Depending on the specific inhibitor, different approaches might be employed, such as small molecule inhibitors, peptides, or other types of chemical agents. These inhibitors are often characterized through biochemical assays that assess their binding affinity to Slfn13, as well as through studies that examine their impact on protein function in vitro. The design and optimization of these inhibitors involve detailed knowledge of the protein's structure and the specific biochemical pathways it influences. By modulating Slfn13 activity, researchers can gain insight into the complex biological roles of Schlafen proteins in cellular regulation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Interferes with transcription processes, potentially influencing Slfn13 function. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Affects protein translation in eukaryotic cells, possibly impacting Slfn13's role in cellular differentiation. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $315.00 | ||
CDK4/6 inhibitor, affecting cell cycle progression which can indirectly modulate Slfn13's function in cell proliferation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
A mTOR inhibitor, potentially affecting cellular processes linked with Slfn13. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Kinase inhibitor which can modulate various pathways and potentially impact Slfn13's role. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Histone deacetylase inhibitor that can influence gene expression and indirectly affect Slfn13-associated processes. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
Affects RNA processing, potentially influencing Slfn13-related pathways. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $62.00 $112.00 $214.00 $342.00 | 74 | |
EGFR inhibitor that can influence cell proliferation pathways possibly associated with Slfn13. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Proteasome inhibitor which can affect protein turnover, indirectly influencing Slfn13 function. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Rho-associated protein kinase inhibitor, affecting cell differentiation processes potentially related to Slfn13. | ||||||